BLFS BIOLIFE SOLUTIONS INC

Overview and Growth

In fiscal 2025, BIOLIFE SOLUTIONS INC recorded $96.21M of revenue, net loss of $4.59M, and an operating cash inflow of $20.11M. The $96.21M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. The top line expanded 28.9% from $74.65M in fiscal 2024, increasing the company’s operating scale. The company reported diluted EPS of -$0.10, adding a shareholder-level measure to the absolute income figures considered below. Total assets stood at $405.88M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Asset turnover was 0.24x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

After reported cost of revenue, the company retained $62.12M as gross profit before recognizing operating expenses and other items. Gross margin was 64.6%, so that share of each revenue unit remained after the cost of revenue reported for the period. The reported operating result was an operating loss of $16.60M, reflecting costs that exceeded gross profit. Relative to revenue, the operating deficit measured 17.3%, showing the shortfall after operating costs. The bottom-line result was a net loss of $4.59M after operating, financing, tax, and other recognized items. Net margin was -4.8%, reflecting a loss equal to 4.8% of reported revenue. The company reported a pretax loss of $12.08M, before the effect of income taxes. Measured against revenue, the pretax deficit represented 12.6%. The company recognized $49.00K of income tax for the period, completing the transition from pretax income to net income. Relative to period-end equity, the net loss represented 1.2%. The net loss equaled 1.1% of period-end assets, showing the deficit relative to the asset base.

Liquidity and Capital Structure

Total assets were $405.88M, supported by $34.00M of liabilities and $371.89M of shareholder equity. At period end, current assets of $136.56M compared with current liabilities of $22.98M, defining the company’s short-term resource position. The current ratio was 5.94x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Reported cash and equivalents were $33.04M, separating immediately recognizable cash resources from the rest of the current-asset base. Cash and equivalents represented 143.8% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Borrowings totaled $5.00M, adding a fixed financing obligation alongside the company’s equity capital. Debt equaled 0.01x of book equity, describing the relative scale of borrowing and shareholder capital. The debt-to-assets relationship was 1.2%, comparing borrowing with the total asset balance. The liabilities-to-assets relationship was 8.4%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 8.1%, a balance-sheet composition measure rather than a liquidity forecast. Total assets were 1.6% higher than fiscal 2024 assets of $399.49M, measuring the company’s own balance-sheet change. Book equity was 6.6% higher than fiscal 2024 equity of $348.91M, showing how shareholder capital changed year over year.

Cash Flow and Earnings Quality

Operating activities produced a cash inflow of $20.11M, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. Capital expenditures used $9.48M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Relative to operating cash flow, capital expenditures measured 47.1%, connecting investment intensity with the company’s cash-generation base. The combination of operating cash flow and capital spending produced $10.64M of positive free cash flow for the period. Free cash flow represented 11.1% of revenue, linking post-investment cash generation with the company’s operating scale. Free cash flow equaled 2.6% of total assets, relating post-investment cash generation to the company’s resource base.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.